<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60315">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01805635</url>
  </required_header>
  <id_info>
    <org_study_id>RNN/23/13/KE</org_study_id>
    <nct_id>NCT01805635</nct_id>
  </id_info>
  <brief_title>PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases</brief_title>
  <official_title>Evaluation of the Relationship Between the Parameters of Pulmonary Function (PF) and the Concentration of Fractional Exhaled Nitric Oxide (FeNO) and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Universtity of Lodz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical Universtity of Lodz</source>
  <oversight_info>
    <authority>Poland: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the influence of kind of allergic disease, allergic
      profile, allergen exposure, treatment method on lung function parameters, fractional exhaled
      nitric oxide level in children suspected and being diagnosed due to allergic diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to assess the influence of kind of allergic disease, allergic
      profile, allergen exposure, treatment method on lung function parameters, fractional exhaled
      nitric oxide (FeNO) level in children suspected and being diagnosed due to allergic
      diseases.

      Study will be retrospective, conducted in all children diagnosed in the years of 2005-20012
      in Laboratory of lung function tests of Department of Pediatrics and Allergy, Medical
      University of Lodz, N. Copernicus Hospital, Lodz, Poland. The investigators will analyse
      5500 male an female children 5-18 year old suspected and being diagnosed due to allergic
      diseases. In these children nearly 3000 FeNO measurements, 65000 spirometry measurements,
      22000 whole-body plethysmography measurements and 48000 occlusion resistance measurements
      were performed between the years  of 2005-2012.

      The investigators  will retrospectively evaluate following data from medical documentation
      of patients:

        1. FeNO levels.

        2. Allergic disease diagnosis.

        3. Immunoglobulin E (IgE) specific levels.

        4. Treatment (drugs and dosages).

        5. Lung function parameters (spirometry, whole-body plethysmography, occlusion resistance,
           bronchial reversibility test).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Allergic disease diagnosis</measure>
    <time_frame>7 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Allergic disease diagnosis. The diagnosis and the severity of asthma, allergic rhinitis and atopic dermatitis and other allergic diseases universally established by the doctors (allergologists) according to standard definitions of  diseases in the latest guidelines</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung function (LF)</measure>
    <time_frame>7 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>spirometry, whole-body pletysmography, occlusion resistance, bronchial reversibility test</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Fractional exhaled nitric oxide (FeNO)</measure>
    <time_frame>7 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Fractional exhaled nitric oxide (Sievers equipment)</description>
  </other_outcome>
  <other_outcome>
    <measure>Immunoglobulin E (IgE) allergen specific</measure>
    <time_frame>7 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Immunoglobulin E (IgE) allergen specific (ELISA method)</description>
  </other_outcome>
  <other_outcome>
    <measure>Treatment of asthma (drugs and dosages)</measure>
    <time_frame>7 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Treatment of asthma (drugs and dosages last 3 months before measurement of lung function parameters and FeNO)</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5500</enrollment>
  <condition>Asthma</condition>
  <condition>Allergic Rhinitis</condition>
  <condition>Atopic Dermatitis</condition>
  <condition>Urticaria</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Children suspected of allergic diseases</arm_group_label>
    <description>Children suspected of allergic diseases No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Children suspected of allergic diseases</arm_group_label>
    <other_name>No intervention</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      IgE specific allergen antibodies
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children with allergic diseases, healthy children.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children with allergic diseases, healthy children.

        Exclusion Criteria:

          -  Other serious diseases.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Iwona Stelmach, MDPhDProf</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tomasz Grzelewski, MDPhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Iwona Stelmach, MDPhDProf</last_name>
    <phone>48426895972</phone>
    <email>alergol@kopernik.lodz.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tomasz Grzelewski, MD PhD</last_name>
    <phone>48426895972</phone>
    <email>alergol@kopernik.lodz.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital</name>
      <address>
        <city>Lodz</city>
        <zip>93-513</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iwona Stelmach, MDPhDProf</last_name>
      <phone>48426895972</phone>
      <email>alergol@kopernik.lodz.pl</email>
    </contact>
    <contact_backup>
      <last_name>Tomasz Grzelewski, MDPhD</last_name>
      <phone>48426895972</phone>
      <email>alergol@kopernik.lodz.pl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 6, 2013</lastchanged_date>
  <firstreceived_date>February 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical Universtity of Lodz</investigator_affiliation>
    <investigator_full_name>Iwona Stelmach</investigator_full_name>
    <investigator_title>MDPhDProf</investigator_title>
  </responsible_party>
  <keyword>Children</keyword>
  <keyword>Asthma</keyword>
  <keyword>Allergic rhinitis</keyword>
  <keyword>Atopic dermatitis</keyword>
  <keyword>Urticaria</keyword>
  <keyword>Healthy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Urticaria</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
